Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 33
- Uncategorized
Greenrise begrüßt Entwicklungen in der Cannabispolitik in Deutschland
Das Unternehmen bereitet sich auf die mögliche Legalisierung von Cannabis für Erwachsene in Deutschland vor.
- CBD Market
SEED Innovations ramps up investment in South West Brands
The company has now invested a total of £500,000 in South West Brands.
- Uncategorized
Whitehouse remarks on “wrongful detainment” of Griner for Russian cannabis charges
The basketball star has been sentenced to nine years for allegedly smuggling cannabis medicines into Russia.
- Companies
Love Hemp sees sales drop by 16%, expects revenues of £3.6m
Love Hemp Group has stated it is expecting to report total revenues of £3.6m for the financial year ending 30 June 2022, which it says represents revenues slightly ahead of management expectations.
- Cultivation
Biologists identify “hacks” cannabis uses to make cannabinoids
The research provides insight into how trichomes create high quantities of cannabinoids without the plant poisoning itself.
- Medical
Khiron gains German distribution capabilities with new acquisition
Khiron Life Sciences has completed the acquisition of Pharmadrug Production GmbH.
- Uncategorized
Khiron gewinnt mit neuer Akquisition deutsche Vertriebskapazitäten
Khiron Life Sciences hat die Übernahme der Pharmadrug Production GmbH abgeschlossen.
- CBD Market
B3 Labs discusses the future of the consumer cannabis industry
CEO of UK-based B3 Labs, Marc Burbidge, speaks to Cannabis Wealth about the UK’s Novel Foods process and shares his outlook for the future of the consumer cannabis industry.
- Opinion
Opinion: former Juicy Fields CEO shares his thoughts on the case
“I might be off the mark, but I don’t think this was an intended Ponzi Scheme,” Willem van der Merwe.
- Medical
Switzerland’s amendment on medical cannabis comes into force
The Swiss government announced in June that rules for medical cannabis will be simplified.
- CBD Market
Former Special Forces soldier, Jason Fox, partners with fourfive CBD
Presenter and former soldier, Fox, will be shares his experience with CBD.
- Medical
Cresco Pharma to acquire Australia’s Health House for $4.6m
The acquisition will help further Cresco’s presence in Europe and the UK.
